| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $442K | — | -70.8% |
| Cost of Revenue | $30K | — | -97.6% |
| Gross Profit | $412K | — | +62.8% |
| R&D Expense | $0 | — | — |
| SG&A Expense | $223K | — | +1.8% |
| Operating Income | -$413K | — | +49.7% |
| Pre-tax Income | -$660K | — |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $538K | +8.2% | -18.1% |
| Current Assets | $3.4M | +6.4% | -27.5% |
| Total Assets | $9.0M | -5.7% | -0.7% |
| Current Liabilities | $7.2M | +12.6% | +65.8% |
| Total Liabilities | $7.3M | +11.6% | +58.9% |
| Stockholders' Equity |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$776K | — | +11.0% |
| Investing Cash Flow | -$3K | — | -103.5% |
| Financing Cash Flow | $759K | — | -23.2% |
| +53.5% |
| Net Income | -$660K | — | +53.5% |
| EPS (Basic) | -$0.21 | — | -425.0% |
| EPS (Diluted) | -$0.21 | — | -425.0% |
| $1.6M |
| -44.3% |
| -62.9% |